[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351554-105":59,"doc-detail-351554-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","replication-protein-a-protects-lagging-strand-gaps-restricting-parp-inhibitor-induced-synthetic-lethality-in-brca1-deficient-tumors","Replication protein A protects lagging strand gaps, restricting PARP inhibitor-induced synthetic lethality in BRCA1-deficient tumors","","Replication Protein A (RPA) is a single-stranded DNA-binding protein required to maintain genome integrity during replication, repair, and recombination. This study defines how a small-molecule RPA inhibitor triggers functional RPA exhaustion. Using non-small cell lung cancer and BRCA1-deficient breast and ovarian models, RPA is shown to sustain fork speed and enable replication restart after stalling. Disruption of fork-associated gap suppression and Okazaki fragment processing increases reliance on RPA to protect ssDNA. RPA inhibition worsens genome instability and PARP inhibitor outcomes in BRCA1-deficient cancers, reducing ssDNA gap protection, causing chromosome shattering, and driving cell death. In vivo genetic and pharmacologic ssDNA accumulation with RPA exhaustion produces therapeutic efficacy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/replication-protein-a-protects-lagging-strand-gaps-restricting-parp-inhibitor-induced-synthetic-lethality-in-brca1-deficient-tumors/351554/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/replication-protein-a-protects-lagging-strand-gaps-restricting-parp-inhibitor-induced-synthetic-lethality-in-brca1-deficient-tumors/351554.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does Replication Protein A (RPA) play in genome integrity?","Question",{"text":112,"@type":113},"RPA binds single-stranded DNA and is essential for preserving genome integrity during DNA replication, repair, and recombination.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does RPA inhibition affect replication in cancer models?",{"text":117,"@type":113},"A small-molecule RPA inhibitor blocks RPA–ssDNA interaction, impairing fork speed maintenance and replication restart after fork stalling.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are BRCA1-deficient tumors particularly sensitive to PARP inhibitors in the presence of RPA inhibition?",{"text":121,"@type":113},"BRCA1 deficiency promotes lagging strand gaps, and RPA inhibition disrupts ssDNA gap protection, leading to genome instability, chromosome shattering, and cell death.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351554,1790167178,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Replication protein A protects lagging strand gaps, restricting PARP inhibitor-induced synthetic lethality in BRCA1-deficient tumors  \nPamela S VanderVere-Carozza1 ,†, Matthew R Jordan 1,4 ,†, Joy E Garrett2 , Karen E Pollok3,4 , Katherine S Pawelczak5 , John J Turchi 1,4,5 ,*  \n1 Department of Biochemistry, Molecular Biology and Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, United States  \n2 Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, United States  \n3 Herman B. Wells Center for Pediatric Research, Departments of Pediatrics, Biochemistry, Molecular Biology and Pharmacology, Medical and Molecular Genetics, Indiana University, Indianapolis, IN 46202, United States  \n4 Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, United States  \n5 NERx BioSciences, Indianapolis, IN 46220, United States  \n∗ To whom correspondence should be addressed. Email: [jturchi@iu.edu](jturchi@iu.edu)[ ](jturchi@iu.edu)†These authors contributed equally to this work.  \nAbstract  \nReplication Protein A (RPA) is a key single-stranded DNA (ssDNA)-binding protein essential for maintaining genome integrity during DNA replication, repair, and recombination. In this study, we elucidate the mechanisms by which a small-molecule RPA inhibitor induces functional RPA exhaustion. Using non-small cell lung cancer and BRCA1-deficient breast and ovarian cancer models, we demonstrate that RPA is critical for sustaining replication fork speed under normal conditions and for facilitating replication restart following fork stalling. Disruption of replication fork-associated processes, including Okazaki fragment processing and ssDNA gap suppression, increases cellular dependence on RPA for ssDNA protection. Chemical inhibition of RPA exacerbates genome instability in BRCA1-deficient cancer models treated with PARP inhibitors, leading to loss of ssDNA gap protection, chromosome shattering, and ultimately, cell death. Combining genetic and pharmacologic approaches to induce ssDNA accumulation alongside RPA exhaustion in vivo shows therapeutic efficacy in BRCA1-deficient breast cancer. These findings provide a mechanistic framework for targeting RPA-mediated ssDNA protection as a therapeutic strategy in cancers experiencing endogenous or therapy-induced replication stress.  \nGraphical abstract  \nIntroduction  \nRecent advances in our understanding of DNA damage response (DDR) signaling have opened up an array of opportunities to treat human cancers [1] . The DDR is initiated by phosphatidylinositol 3-kinase-related kinases (PIKKs) ATM, ATR, and DNA-PK, each of which responds to different DNA structures [2] . Each PIKK requires a sensor protein to bind to DNA: Ku binds to double-stranded DNA breaks (DSBs) to activate DNA-PK, MRN binds to DSBs to activate ATM, and  \nreplication protein A (RPA) binds to single-stranded DNA (ssDNA) to activate ATR. Once activated, these kinases signal to downstream kinases and other effector proteins to regulate the cell cycle and DNA replication and promote DNA repair. If the damage is not repaired, cell death occurs via apoptosis or mitotic catastrophe. RPA, a human ssDNA-binding protein, is a crucial sensor of elevated ssDNA levels resulting from replication stress (RS) and DNA damage [3] . Binding of the ATR-interacting protein (ATRIP) to the RPA–ssDNA  \nReceived: July 9, 2025. Revised: March 19, 2026. Accepted: April 9, 2026 © The Author(s) 2026. Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.  \n2 VanderVere-Carozza et al.  \ncomplex results in the activation of ATR and initiation of the DDR [4], limiting","cbCairwFSwjgYVeF","https://ap.wps.com/l/cbCairwFSwjgYVeF","pdf",3698496,15,"English","# Abstract\n# Introduction\n## DNA damage response signaling and RPA as an ssDNA sensor\n## RPA inhibition and replication stress response\n## PARP inhibitor sensitivity and lagging strand gap biology","[{\"question\":\"What role does Replication Protein A (RPA) play in genome integrity?\",\"answer\":\"RPA binds single-stranded DNA and is essential for preserving genome integrity during DNA replication, repair, and recombination.\"},{\"question\":\"How does RPA inhibition affect replication in cancer models?\",\"answer\":\"A small-molecule RPA inhibitor blocks RPA–ssDNA interaction, impairing fork speed maintenance and replication restart after fork stalling.\"},{\"question\":\"Why are BRCA1-deficient tumors particularly sensitive to PARP inhibitors in the presence of RPA inhibition?\",\"answer\":\"BRCA1 deficiency promotes lagging strand gaps, and RPA inhibition disrupts ssDNA gap protection, leading to genome instability, chromosome shattering, and cell death.\"}]","Replication protein A protects lagging strand gaps, restricting PARP inhibitor-induced synthetic lethality in BRCA1-deficient tumors | PDF",1790094694,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83af547163ab24efcae0db0e848027c7.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f653f87a15b0541f76e5a1d96ebf23c7.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2f22aafc380095870659601458ea2c5.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afe631cc4cf7c42f3b4be6a4ab09446e.webp",980,1268]